APA (7th ed.) Citation

M, S., J, N., C, Z., J, M., Y, Y., Z, W., . . . D, Z. (2025). Erratum: Author correction to "Microbial metabolite 3-indolepropionic acid alleviated PD pathologies by decreasing enteric glia cell gliosis via suppressing IL-13Rα1 related signaling pathways" [Acta Pharm Sin B 15 (2025) 2024-2038]. Acta pharmaceutica Sinica. B, 15(9), 4972. https://doi.org/10.1016/j.apsb.2025.06.017

Chicago Style (17th ed.) Citation

M, Shang, et al. "Erratum: Author Correction to "Microbial Metabolite 3-indolepropionic Acid Alleviated PD Pathologies by Decreasing Enteric Glia Cell Gliosis via Suppressing IL-13Rα1 Related Signaling Pathways" [Acta Pharm Sin B 15 (2025) 2024-2038]." Acta Pharmaceutica Sinica. B 15, no. 9 (2025): 4972. https://doi.org/10.1016/j.apsb.2025.06.017.

MLA (9th ed.) Citation

M, Shang, et al. "Erratum: Author Correction to "Microbial Metabolite 3-indolepropionic Acid Alleviated PD Pathologies by Decreasing Enteric Glia Cell Gliosis via Suppressing IL-13Rα1 Related Signaling Pathways" [Acta Pharm Sin B 15 (2025) 2024-2038]." Acta Pharmaceutica Sinica. B, vol. 15, no. 9, 2025, p. 4972, https://doi.org/10.1016/j.apsb.2025.06.017.